## Abstract Epstein–Barr virus (EBV) is implicated in the pathogenesis of several lymphoid and epithelial neoplasms. Latent membrane protein 1 (LMP1) is the major viral oncogene and it is controversial whether tumor LMP1 variants reflect their geographical predominance or are associated with enhanc
Expression of the simian epstein-barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques
✍ Scribed by Sabine Blaschke; Horst Hannig; Christian Buske; Franz-J. Kaup; Gerhard Hunsmann; Walter Bodemer
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 459 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0146-6615
- DOI
- 10.1002/jmv.2009
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
During the course of simian immunodeficiency virus (SIV) infection, nearly 15% of rhesus macaques (Macaca mulatta) and up to 40% of cynomolgus macaques (Macaca fascicularis) developed SIV‐associated non‐Hodgkin's lymphomas. Most of these malignant lymphomas harbored lymphocryptoviruses, which are closely related to the human Epstein‐Barr virus (EBV; Herpesvirus M. mulatta and Herpesvirus M. fascicularis). To characterize the oncogenic role of simian EBV infection for lymphomagenesis during SIV infection, expression of the EBV‐encoded latent membrane protein‐1 (LMP‐1) was analyzed in malignant lymphomas of SIV‐infected rhesus macaques. Nine seropositive rhesus macaques suffering from B‐cell lymphomas during the late phase of SIV infection were euthanized. Latency stages of EBV infection within malignant lymphomas and simian EBV‐infected lymphoblastoid cell lines (LCL8664, H50) were characterized by analyzing expression of the EBV‐encoded nuclear antigens EBNA‐1, EBNA‐2, and small RNAs EBER1/2. In parallel, the presence of viral LMP‐1 transcripts was assessed by reverse transcription‐polymerase chain reaction (RT‐PCR) and in situ hybridization. Results were compared with findings in AIDS‐associated malignant lymphomas in two patients infected with human immunodeficiency virus (HIV)‐1. Rhesus macaques developed high‐grade B‐cell lymphomas of the centroblastic (five of nine), immunoblastic (two of nine), centroblastic‐centrocytic (one of nine), and Burkitt‐like (one of nine) subtypes within 18–29 months postinfection with SIV~mac~251/32H. The presence of Herpesvirus M. mulatta was detected in eight of nine cases. Transcription of the viral oncogene LMP‐1 could be demonstrated within the simian EBV‐infected cell lines as well as in four of nine SIV‐associated malignant lymphomas. These four cases and both of the HIV‐1–related non‐Hodgkin's lymphomas expressed the full spectrum of latent EBV gene products (LMP‐1, EBER1/2, EBNA‐1, EBNA‐2) and were thus classified as latency type III stages of EBV infection. Simian EBV infection was demonstrated in 90% of lymphomas in SIV‐infected rhesus macaques. Analysis of LMP‐1 expression suggests an important role for this viral oncogene in the pathogenesis of both SIV and HIV‐1–associated malignant lymphomas. J. Med. Virol. 65:114–120, 2001. © 2001 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract A large group of juvenile Hodgkin's disease patients (n = 242, mean age 11.7 years, 75% [n = 181] seropositive) was evaluated for anti‐Epstein‐Barr virus (EBV) antibody responses and the presence of EBV‐encoded EBER‐RNA and latent membrane protein‐1 (LMP1)‐protein expression in the tumo
## Abstract Chronic active Epstein–Barr virus (EBV) infection is a severe systemic disease associated with high rates of mortality and morbidity. Recent studies suggest that the clonal expansion of EBV‐infected T or natural killer cells plays a crucial role in the pathogenesis of chronic active EBV
Two genes encoding the latent membrane protein 1 (LMP1) of the Epstein-Barr virus (EBV) were isolated from a single case of Hodgkin's disease (HD) and were tested for their biological activities. The LMP1 gene from the Reed-Sternberg cells contained point mutations relative to the prototype LMP1 gen